Navigation Links
Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
Date:7/29/2008

PHILADELPHIA, July 29 /PRNewswire-USNewswire/ -- Bladder problems may leave a mark on the brain, by changing patterns of brain activity, possibly contributing to disrupted sleep and problems with attention. For one in six Americans who have overactive bladder, the involuntary bladder contractions that often trigger more frequent urges to urinate, such mind-body connections may be of more than academic interest.

"We often tend to focus on just one organ, but here we see how an abnormal organ affects the whole organism," said behavioral scientist Rita J. Valentino, Ph.D., of The Children's Hospital of Philadelphia, who led the research describing how an overactive bladder altered nervous system activity in animals.

The study appeared in the July 21 online edition of the Proceedings of the National Academy of Sciences.

Overactive bladder, while it occurs in a variety of conditions in both adults and children, is especially prevalent among elderly men, in whom an enlarged prostate gland partially obstructs the flow of urine and makes bladder muscles contract involuntarily. Valentino's research team mimicked the condition in an animal model by surgically constricting the outlet of urine from rats' bladders.

Building on their previous investigations of the neural circuits between the bladder and the brain, the researchers found that two small brain structures, the Barrington's nucleus and the locus ceruleus, developed abnormal activity as a result of the bladder obstruction. In particular, the locus ceruleus showed persistently high activity, and this resulted in an abnormal electroencephalogram (EEG) recorded from the cortex, the broad mass of the brain that governs higher-level functions. In people, abnormally high activity in the cortex may result in disordered sleep, anxiety and difficulty in concentrating.

Valentino said further studies are necessary to analyze the direct connections between heightened brain activity and spec
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
2. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
3. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
4. Study Findings Show Infection Control Intervention Helps Keep Kids in School
5. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
6. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
7. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
8. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
9. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
10. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
11. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...JOHANNESBURG, November 25 ,iThemba ...ery announced today,that they have signed a collab..., services. , Pyxis,s world class computa... be coupled with iThemba,s service division to pro...projects identified through Pyxis,international c...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
(Date:11/24/2009)...-- ,, WHAT: Rom Houbens, a Belgian man though...uto accident, was actually fully conscious and awa...Morning America segment. The DynaVox EyeMax was f...th Locked-in Syndrome and other conditions can unl...ca -- Tuesday, November 24 available online at ...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 1DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 2DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 3The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 55444 1The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 55444 2Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 1Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 2Movember Presents at LIVESTRONG 28R 29 Global Cancer Summit in Dublin Ireland in Support of Mens Health 55440 3
...ilotinib) Effective in 77% of Patients Resistant o...rly) Phase of Chronic,Myeloid Leukaemia (CML)(1), ...e Root Cause of CML,Whilst Providing an Acceptable...na Expands CML Portfolio for Novartis, Providing E...ients With Tasigna(R) and the CML,Gold-Standard, G...
...resent preliminary Phase II data for the adj... mechanically-ventilated patients,...ether with Nektar Therapeutics (Nasdaq: NKTR ), t...on their unique drug-device combination Amikacin,I...l meeting. Amikacin,Inhale, currently being studie...
Other Medicine Technology:Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 2Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 3Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 4Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib) 5Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7
(Date:11/27/2009)...ecipes.com , theworld,s#1foodsite,receivedrecord-...ionvisitorsthedaybeforeThanksgiving,providingaclea...eyear.TheaverageThanksgivingmealin2009weighedinat2...ar,sfeast.AccordingtotheAllrecipessite, SweetPotat...pe,acontrastfromlastyear,spopular HomestyleTurkeyt...
(Date:11/27/2009)...ilingual coloring books designed for children ages...ty to educate - inform parents and children alike ...osuars to ABC,S and a host of other topics. , ...ber 27, 2009 -- Today’s children have enough...y hour of the day, but one of the oldest and simpl...
(Date:11/27/2009)...active anatomy education apps from Modality and Li...nces learning opportunities for iPhone and iPod to...November 27, 2009 -- Modality, Inc. and Lippinco...ters Kluwer Health, today announced the availabili...Store. Clemente’s Anatomy, Rohen’s Pho...
(Date:11/26/2009)...RNewswire/ -- The diabetes population in the Unite... and annual medical spending on the disease is pro...oday, according to a study published in the Decemb...ng Diabetes ® Program (NCDP), a program of No...om the University of Chicago. ,, According to t...
(Date:11/26/2009)...olybdate (TM) has been shown in studies to be effe...e caused by an overload of copper, and certain met...however, is known about how the drug works at the ...rn University researchers now has provided an inva... bound to copper-loaded metallochaperones. The dru...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...e most disabling aspect of Tourette syndrome is th...another disorder. The most frequent co-occurring ...icit hyperactivity disorder (ADHD), though the cau... New research published in the April 13 edition of...
...il 15 Washington State Nurses Association,(WSNA),...more than 15,000 RNs,in Washington State, is a fou...(NFN) and is playing a leadership role as the new ...nization that provides,WSNA and other member state...
...Reduces 2009 Operating Expenses to Address Continu...st-Quarter 2009 Financial Results on Tuesday, May ...c. (Nasdaq: CYNO ), a leading developer and ma... March 31, 2009. , , Reflecting continued softnes...
...il 15 /PRNewswire/ - FormularyDecisions.com, an on...eing officially introduced at AMCP,s 21st Annual M...ng Committee of prominent healthcare decision make... economic models, and other content that may be us...
... RxSamplesNow.com is a New, Web-Based Phar...to all Prescribing U.S. Healthcare Professionals. ...ufacturers Together in an Online Community at www...rug Will Be Available in a Variety of Formats. , ...
... New York law firm to represent executive ...ord from Obama Administration on recognition of co... New York (Lexis Nexis) April 15, 2009 -- Taub...llenges, has been retained by Local 2222 of the Am...
Other Medicine News:Health News:Tourette syndrome misconceptions only one battle for patients 2Health News:Washington State Nurses Association Announces Formation of a New National Nurses Union 2Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 2Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 3Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 4Health News:Innovative Decision Support Tool Introduced at AMCP Annual Meeting 2Health News:Online Sampling Service for Healthcare Prescribers and Drug Manufacturers Launched by RxSamplesNow.com 2Health News:Online Sampling Service for Healthcare Prescribers and Drug Manufacturers Launched by RxSamplesNow.com 3Health News:Taubman Kimelman & Soroka Retained by AFGE Local 2222 to Advise in Organizing of New York and New Jersey Transportation Security Officers 2
Liquichek Autoimmune Controls - ANA
Lyphochek Assayed Chemistry Control
Lyphochek Benzo/TCA Control Set A
Lyphochek Benzo/TCA Control Set B
Medicine Products: